Clinical trials
Recruiting Myeloproliferative Disorders trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda Ospedaliero-Universitaria di Parma | 4 |
| Incyte Corporation | 2 |
| Celgene | 1 |
| Cogent Biosciences, Inc. | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Istituto Clinico Humanitas | 1 |
| Novartis Pharmaceuticals | 1 |
| University of Milano Bicocca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 12 |
| Primary Myelofibrosis | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoproliferative Disorders | 2 |
| Multiple Myeloma | 2 |
| Thrombocythemia, Essential | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blast Crisis | 1 |
| Carcinoma, Squamous Cell | 1 |
| Hematologic Diseases | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.